Receptor protein tyrosine phosphatase-receptor tyrosine kinase substrate screen identifies EphA2 as a target for LAR in cell migration

Molecular and Cellular Biology

Volumn 33, Issue 7, 2013, Pages 1430-1441

  Lee, Hojin ^a   Bennett, Anton M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; PROTEIN; PROTEIN EPHA 2; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CELL MIGRATION; CONTROLLED STUDY; GENOME; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; RNA FINGERPRINTING; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL LINE; CELL MOVEMENT; CERCOPITHECUS AETHIOPS; COS CELLS; EPITHELIAL CELLS; HEK293 CELLS; HUMANS; ONCOGENE PROTEINS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RECEPTOR, EPHA2; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES;

EID: 84875235384     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01708-12     Document Type: Article

References (57)

1. Soulsby M, Bennett AM. 2009. Physiological signaling specificity by protein tyrosine phosphatases. Physiology (Bethesda) 24:281-289.
2. Tonks NK. 2006. Protein tyrosine phosphatases: from genes, to function, to disease. Nat. Rev. Mol. Cell Biol. 7:833- 846.
3. Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan CC, Ramachandran C, Gresser MJ, Tremblay ML, Kennedy BP. 1999. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase- 1B gene. Science 283:1544 -1548.
4. Bentires-Alj M, Neel BG. 2007. Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer. Cancer Res. 67:2420 -2424.
5. Chan G, Kalaitzidis D, Neel BG. 2008. The tyrosine phosphatase Shp2 (PTPN11) in cancer. Cancer Metastasis Rev. 27:179 -192.
6. Julien SG, Dube N, Hardy S, Tremblay ML. 2011. Inside the human cancer tyrosine phosphatome. Nat. Rev. Cancer 11:35- 49.
7. Klaman LD, Boss O, Peroni OD, Kim JK, Martino JL, Zabolotny JM, Moghal N, Lubkin M, Kim YB, Sharpe AH, Stricker-Krongrad A, Shulman GI, Neel BG, Kahn BB. 2000. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in proteintyrosine phosphatase 1B-deficient mice. Mol. Cell. Biol. 20:5479 -5489.
8. Ostman A, Hellberg C, Bohmer FD. 2006. Protein-tyrosine phosphatases and cancer. Nat. Rev. Cancer 6:307-320.
9. Alonso A, Sasin J, Bottini N, Friedberg I, Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J, Mustelin T. 2004. Protein tyrosine phosphatases in the human genome. Cell 117:699 -711.
10. Andersen JN, Mortensen OH, Peters GH, Drake PG, Iversen LF, Olsen OH, Jansen PG, Andersen HS, Tonks NK, Moller NP. 2001. Structural and evolutionary relationships among protein tyrosine phosphatase domains. Mol. Cell. Biol. 21:7117-7136.
11. Bixby JL. 2001. Ligands and signaling through receptor-type tyrosine phosphatases. IUBMB Life 51:157-163.
12. den Hertog J, Ostman A, Bohmer FD. 2008. Protein tyrosine phosphatases: regulatory mechanisms. FEBS J. 275:831- 847.
13. Jiang G, den Hertog J, Hunter T. 2000. Receptor-like protein tyrosine phosphatase alpha homodimerizes on the cell surface. Mol. Cell. Biol. 20:5917-5929.
14. Toledano-Katchalski H, Tiran Z, Sines T, Shani G, Granot-Attas S, den Hertog J, Elson A. 2003. Dimerization in vivo and inhibition of the nonreceptor form of protein tyrosine phosphatase epsilon. Mol. Cell. Biol. 23:5460 -5471.
15. Bilwes AM, den Hertog J, Hunter T, Noel JP. 1996. Structural basis for inhibition of receptor protein-tyrosine phosphatase-alpha by dimerization. Nature 382:555-559.
16. Jiang G, den Hertog J, Su J, Noel J, Sap J, Hunter T. 1999. Dimerization inhibits the activity of receptor-like protein-tyrosine phosphatase-alpha. Nature 401:606-610.
17. Felberg J, Johnson P. 1998. Characterization of recombinant CD45 cytoplasmic domain proteins. Evidence for intramolecular and intermolecular interactions. J. Biol. Chem. 273:17839 -17845.
18. Streuli M, Krueger NX, Thai T, Tang M, Saito H. 1990. Distinct functional roles of the two intracellular phosphatase like domains of the receptor-linked protein tyrosine phosphatases LCA and LAR. EMBO J. 9:2399 -2407.
19. Blanchetot C, den Hertog J. 2000. Multiple interactions between receptor protein-tyrosine phosphatase (RPTP) alpha and membrane-distal protein- tyrosine phosphatase domains of various RPTPs. J. Biol. Chem. 275: 12446-12452.
20. Blanchetot C, Tertoolen LG, Overvoorde J, den Hertog J. 2002. Intraand intermolecular interactions between intracellular domains of receptor protein-tyrosine phosphatases. J. Biol. Chem. 277:47263- 47269.
21. Lemmon MA, Schlessinger J. 2010. Cell signaling by receptor tyrosine kinases. Cell 141:1117-1134.
22. Li S, Depetris RS, Barford D, Chernoff J, Hubbard SR. 2005. Crystal structure of a complex between protein tyrosine phosphatase 1B and the insulin receptor tyrosine kinase. Structure 13:1643-1651.
23. Kulas DT, Goldstein BJ, Mooney RA. 1996. The transmembrane protein- tyrosine phosphatase LAR modulates signaling by multiple receptor tyrosine kinases. J. Biol. Chem. 271:748 -754.
24. Kulas DT, Zhang WR, Goldstein BJ, Furlanetto RW, Mooney RA. 1995. Insulin receptor signaling is augmented by antisense inhibition of the protein tyrosine phosphatase LAR. J. Biol. Chem. 270:2435-2438.
25. Chabot C, Spring K, Gratton JP, Elchebly M, Royal I. 2009. New role for the protein tyrosine phosphatase DEP-1 in Akt activation and endothelial cell survival. Mol. Cell. Biol. 29:241-253.
26. Debnath J, Muthuswamy SK, Brugge JS. 2003. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in threedimensional basement membrane cultures. Methods 30:256 -268.
27. Lee H, Gaughan JP, Tsygankov AY. 2008. c-Cbl facilitates cytoskeletal effects in v-Abl transformed fibroblast through Rac1- and Rap1-mediated signaling. Int. J. Biochem. Cell Biol. 40:1930 -1943.
28. Lee H, Tsygankov AY. 2010. c-Cbl regulates glioma invasion through matrix metalloproteinase 2. J. Cell. Biochem. 111:1169 -1178.
29. Mercan F, Lee H, Kolli S, Bennett AM. 2013. Novel role for SHP-2 in nutrient-responsive control of S6 kinase 1 signaling. Mol. Cell. Biol. 33: 293-306.
30. Jaskolski F, Mulle C, Manzoni OJ. 2005. An automated method to quantify and visualize colocalized fluorescent signals. J. Neurosci. Methods 146:42- 49.
31. Frangioni JV, Neel BG. 1993. Solubilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion proteins. Anal. Biochem. 210:179 -187.
32. Mercan F, Bennett AM. 2010. Analysis of protein tyrosine phosphatases and substrates. Curr. Protoc. Mol. Biol. 91:18.16.1-18.16.17. doi:10.1002 /0471142727.mb1816s91.
33. Shintani T, Ihara M, Sakuta H, Takahashi H, Watakabe I, Noda M. 2006. Eph receptors are negatively controlled by protein tyrosine phosphatase receptor type O. Nat. Neurosci. 9:761-769.
34. Ahmad F, Considine RV, Goldstein BJ. 1995. Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects. J. Clin. Invest. 95:2806 -2812.
35. Niu XL, Li J, Hakim ZS, Rojas M, Runge MS, Madamanchi NR. 2007. Leukocyte antigen-related deficiency enhances insulin-like growth factor- 1 signaling in vascular smooth muscle cells and promotes neointima formation in response to vascular injury. J. Biol. Chem. 282:19808 -19819.
36. Parri M, Buricchi F, Taddei ML, Giannoni E, Raugei G, Ramponi G, Chiarugi P. 2005. EphrinA1 repulsive response is regulated by an EphA2 tyrosine phosphatase. J. Biol. Chem. 280:34008 -34018.
37. Flint AJ, Tiganis T, Barford D, Tonks NK. 1997. Development of "substrate-trapping" mutants to identify physiological substrates of protein tyrosine phosphatases. Proc. Natl. Acad. Sci. U. S. A. 94:1680 -1685.
38. Tiganis T, Bennett AM. 2007. Protein tyrosine phosphatase function: the substrate perspective. Biochem. J. 402:1-15.
39. Fang WB, Brantley-Sieders DM, Hwang Y, Ham AJ, Chen J. 2008. Identification and functional analysis of phosphorylated tyrosine residues within EphA2 receptor tyrosine kinase. J. Biol. Chem. 283:16017-16026.
40. Miao H, Burnett E, Kinch M, Simon E, Wang B. 2000. Activation of EphA2 kinase suppresses integrin function and causes focal-adhesionkinase dephosphorylation. Nat. Cell Biol. 2:62- 69.
41. Holland SJ, Gale NW, Gish GD, Roth RA, Songyang Z, Cantley LC, Henkemeyer M, Yancopoulos GD, Pawson T. 1997. Juxtamembrane tyrosine residues couple the Eph family receptor EphB2/Nuk to specific SH2 domain proteins in neuronal cells. EMBO J. 16:3877-3888.
42. Hu T, Shi G, Larose L, Rivera GM, Mayer BJ, Zhou R. 2009. Regulation of process retraction and cell migration by EphA3 is mediated by the adaptor protein Nck1. Biochemistry 48:6369-6378.
43. Miura K, Nam JM, Kojima C, Mochizuki N, Sabe H. 2009. EphA2 engages Git1 to suppress Arf6 activity modulating epithelial cell-cell contacts. Mol. Biol. Cell 20:1949 -1959.
44. Stein E, Huynh-Do U, Lane AA, Cerretti DP, Daniel TO. 1998. Nck recruitment to Eph receptor, EphB1/ELK, couples ligand activation to c-Jun kinase. J. Biol. Chem. 273:1303-1308.
45. Vindis C, Teli T, Cerretti DP, Turner CE, Huynh-Do U. 2004. EphB1- mediated cell migration requires the phosphorylation of paxillin at Tyr- 31/Tyr-118. J. Biol. Chem. 279:27965-27970.
46. Brantley-Sieders DM, Caughron J, Hicks D, Pozzi A, Ruiz JC, Chen J. 2004. EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation. J. Cell Sci. 117:2037-2049.
47. Miao H, Li DQ, Mukherjee A, Guo H, Petty A, Cutter J, Basilion JP, Sedor J, Wu J, Danielpour D, Sloan AE, Cohen ML, Wang B. 2009. EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt. Cancer Cell 16:9 -20.
48. Taddei ML, Parri M, Angelucci A, Onnis B, Bianchini F, Giannoni E, Raugei G, Calorini L, Rucci N, Teti A, Bologna M, Chiarugi P. 2009. Kinase-dependent and -independent roles of EphA2 in the regulation of prostate cancer invasion and metastasis. Am. J. Pathol. 174:1492-1503.
49. Zhu JH, Chen R, Yi W, Cantin GT, Fearns C, Yang Y, Yates JR, III, Lee JD. 2008. Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling. Oncogene 27:2525-2531.
50. Yu M, Lin G, Arshadi N, Kalatskaya I, Xue B, Haider S, Nguyen F, Boutros PC, Elson A, Muthuswamy LB, Tonks NK, Muthuswamy SK. 2012. Expression profiling during mammary epithelial cell threedimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformation. Mol. Cell. Biol. 32: 3913-3924.
51. De Franceschi L, Biondani A, Carta F, Turrini F, Laudanna C, Deana R, Brunati AM, Turretta L, Iolascon A, Perrotta S, Elson A, Bulato C, Brugnara C. 2008. PTPepsilon has a critical role in signaling transduction pathways and phosphoprotein network topology in red cells. Proteomics 8:4695- 4708.
52. Su J, Muranjan M, Sap J. 1999. Receptor protein tyrosine phosphatase alpha activates Src-family kinases and controls integrin-mediated responses in fibroblasts. Curr. Biol. 9:505-511.
53. Ponniah S, Wang DZ, Lim KL, Pallen CJ. 1999. Targeted disruption of the tyrosine phosphatase PTPalpha leads to constitutive downregulation of the kinases Src and Fyn. Curr. Biol. 9:535-538.
54. Zeng L, Si X, Yu WP, Le HT, Ng KP, Teng RM, Ryan K, Wang DZ, Ponniah S, Pallen CJ. 2003. PTP alpha regulates integrin-stimulated FAK autophosphorylation and cytoskeletal rearrangement in cell spreading and migration. J. Cell Biol. 160:137-146.
55. Müller T, Choidas A, Reichmann E, Ullrich A. 1999. Phosphorylation and free pool of beta-catenin are regulated by tyrosine kinases and tyrosine phosphatases during epithelial cell migration. J. Biol. Chem. 274:10173- 10183.
56. Debant A, Serra-Pages C, Seipel K, O'Brien S, Tang M, Park SH, Streuli M. 1996. The multidomain protein Trio binds the LAR transmembrane tyrosine phosphatase, contains a protein kinase domain, and has separate rac-specific and rho-specific guanine nucleotide exchange factor domains. Proc. Natl. Acad. Sci. U. S. A. 93:5466 -5471.
57. Harrington RJ, Gutch MJ, Hengartner MO, Tonks NK, Chisholm AD. 2002. The C. elegans LAR-like receptor tyrosine phosphatase PTP-3 and the VAB-1 Eph receptor tyrosine kinase have partly redundant functions in morphogenesis. Development 129:2141-2153.